Skip to main content

Anti-Human IFN-Alpha, Rabbit Serum (PAb)

Hero Region

Anti-Human IFN-Alpha, Rabbit Serum (PAb)

Catalog Number: 31101

Unconjugted Rabbit polyclonal antibody against Human IFN-Alpha suitable for use in neutralization, ELISA, Western Blot, immunoprecipitation and immunohistochemistry

$310.00

Pack Size
Product Info

SpecificityBinds well to human IFN-Alpha A (2a), A/D and K (6)
Tested Application
  • Neutralization
Suggested Applications*
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunohistochemistry

 

*Please note that these applications are presented for suggested use only and have not been fully evaluated by PBL

 

This antibody is Immunized by recombinant human IFN-Alpha 2 (alpha 2b).

Specifications

FormulationSupplied frozen in Phosphate buffered saline (PBS)
AntigenRecombinant human interferon alpha 2 (alpha2b), expressed in E.coli
Host SpeciesRabbit
BioactivityMeasured by neutralization of interferon in cytopathic effect inhibition assay using A549 cells challenged with EMCV.
StorageFor retention of full activity store at -70oC or below and avoid repeated freeze/thaw cycles.
Antigen SynonymsInterferon alpha, IFN alpha rabbit polyclonal, IFN-a, interferon alpha rabbit polyclonal, Leukocyte interferon, Leukocyte IFN, alpha interferon, interferon alfa, IFN alfa, interferon a, Type I interferon alpha, Type I IFN alpha

Tech Info & Data

​​​​​​​

Citations

3 Citations

 

  1. Kuri, et al. (2013). Influenza A Virus-Mediated Priming Enhances Cytokine Secretion by Human Dendritic Cells Infected with Streptococcus pneumoniae. Cellular Microbiology, 16 pgs. PMID: 23421931. (link)
  2. Valente, Robert, et al. (2012). Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. PLOS One, 10 pgs. PMID: 22952664. (link)
  3. Richez, Christophe, et al. (2009). Toll-like Receptor 4 Ligands Induce IFN-α Production By Mouse Conventional Dendritic Cells and Human Monocytes After IFN-β Priming1. Journal of Immunology. PMID: 19124725. (link)

 

References

 

  1. Rubinstein, S., Familletti, P.C., and Pestka, S. (1981) J. Virol. 37, 755-758
  2. Budd et al. (1985) Canc. Chem. Pharm. 12:39
  3. Krug et al. Eur. J. Immunol. (2001) 31:2154
  4. Lande et al. J. Immunol. (2003) 170:1174
  5. Jego et al. Immunity (2003) 19:225
  6. Ku et al. J. Exp. Med. (2004) 200:917

Documentation

Certificate of Analysis (CoA) and Safety Data Sheet (SDS)
31101-1 CoA

31101-1 Certificate of Analysis

31101-1 SDS

31101-1 Safety Data Sheet